TWST

#1430
Twist Bioscience Corporation - Common Stock
70.5 5 USD
+2.20%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
70.22
71.04
Range Annuel
23.30
71.04
Changement quotidien
+2.20%
Changement Mensuel
+22.70%
Evolution sur 6 mois
+125.83%
Changement Annuel
+146.59%
Clôture Précédente
69.0 3
Open
70.2 2
Low
70.2 2
High
71.0 4
Volume
391
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 4.39 B
  • Employee 979
  • Founded 2013
  • CEO Emily LeProust
  • Website www.twistbioscience.com
  • Headquarter Delaware, United States
  • FIGI BBG006KDCHJ4
  • Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-21.65
ratio cours/chiffre d'affaires
4.47

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Nouvelles